Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Verve Therapeutics Inc shares valued at $40,761 were sold by Kathiresan Sekar on Apr 02 ’25. At $4.15 per share, Kathiresan Sekar sold 9,822 shares. The insider’s holdings dropped to 346,686 shares worth approximately $1.06 million following the completion of this transaction.
Also, Nickerson Joan sold 2,777 shares, netting a total of over 11,525 in proceeds. Following the sale of shares at $4.15 each, the insider now holds 17,420 shares.
Before that, Ashe Andrew D. had sold 2,681 shares from its account. In a trade valued at $11,126, the insider traded Verve Therapeutics Inc shares for $4.15 each. Upon closing the transaction, the insider’s holdings decreased to 2,681 shares, worth approximately $1.06 million.
As published in their initiating research note from H.C. Wainwright on April 08, 2024, Verve Therapeutics Inc [VERV] has been a Buy and the price target has been revised to $15. Analysts at Canaccord Genuity started covering the stock with ‘”a Buy”‘ outlook in a report released in mid April. As of February 01, 2023, Cantor Fitzgerald has initiated its “Neutral” rating for VERV. Earlier on December 15, 2022, Goldman initiated its rating. Their recommendation was “a Sell” for VERV stock.
Analyzing VERV Stock Performance
During the last five days, there has been a drop of approximately -20.68%. Over the course of the year, Verve Therapeutics Inc shares have dropped approximately -45.92%. Shares of the company reached a 52-week high of $9.31 on 02/18/25 and a 52-week low of $2.86 on 04/09/25. A 50-day SMA is recorded $6.24, while a 200-day SMA reached $5.91.
Support And Resistance Levels for Verve Therapeutics Inc (VERV)
According to the 24-hour chart, there is a support level at 2.89, which, if violated, would cause prices to drop to 2.73. In the upper region, resistance lies at 3.26. The next price resistance is at 3.47. RSI (Relative Strength Index) is 25.60 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.17, which suggests the price will decrease in the coming days. Percent R is at 93.93%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
